Approval · Notice of Compliance 99 · 2004
ADVIL EXTRA STRENGTH CAPLETS: Notice of Compliance 99
Issued March 1, 2004
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 99
- Date
- March 1, 2004
- Company
- Wyeth Consumer Healthcare Inc.Mississauga, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Reason
- Manufacturer name change
- Therapeutic class
- Analgesic, antipyretic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ADVIL EXTRA STRENGTH CAPLETS | 02244577 | Marketed |
| ADVIL GEL CAPLETS | 02230541 | Cancelled Post Market |
| ADVIL IBUPROFEN TABLETS | 01933558 | Marketed |
| ADVIL IBUPROFEN CAPLETS | 01933531 | Marketed |